{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-120278","form_type":"8-K","ticker":"DTIL","cik":"0001357874","company_name":"PRECISION BIOSCIENCES INC","filed_at":"2024-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.249364+00:00","generated_at":"2026-05-30T05:50:59.761832+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Precision BioSciences Q3 revenue $0.6M, net loss $16.4M; PBGENE-HBV enters clinic","bullets":["Revenue $0.6M down from $13.1M YoY; net loss $16.4M ($2.25/share) vs $8.1M loss in Q3 2023.","Cash $121.3M sufficient into H2 2026, supplemented by $22.5M loan from Banc of California (maturing June 2027).","PBGENE-HBV CTA approved in Moldova; patient screening underway; Phase 1 data expected in 2025.","PBGENE-3243 (mitochondrial disease) IND/CTA expected in 2025; regained rights to three Prevail programs under assessment.","Appointed Dr. Murray Abramson SVP Head of Clinical Development and John Fry as Strategic Clinical Advisor for hepatitis."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-120278","json":"https://secwatch.observer/filing/0000950170-24-120278.json","markdown":"https://secwatch.observer/filing/0000950170-24-120278.md","text":"https://secwatch.observer/filing/0000950170-24-120278.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024120278/0000950170-24-120278-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357874/000095017024120278/dtil-20241104.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T05:50:59.761832+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}